BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27007152)

  • 1. Applying of pretreatment extent of disease system in patients with hepatocellular carcinoma after curative partial hepatectomy.
    Qiao G; Cucchetti A; Li J; Cescon M; Ercolani G; Liu G; Pinna AD; Li L; Shen F; Ren J
    Oncotarget; 2016 May; 7(21):30408-19. PubMed ID: 27007152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma.
    Qiao G; Li J; Huang A; Yan Z; Lau WY; Shen F
    J Gastroenterol Hepatol; 2014 Dec; 29(12):2014-20. PubMed ID: 24989634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI.
    Lu W; Dong J; Huang Z; Guo D; Liu Y; Shi S
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1874-8. PubMed ID: 18752560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.
    Liao R; Peng C; Li M; Li DW; Jiang N; Li PZ; Ding X; Wu Q; Du CY; Gong JP
    Cancer Med; 2018 Apr; 7(4):1170-1182. PubMed ID: 29533004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model prediction of long-term prognosis in patients with centrally located hepatocellular carcinoma undergoing hepatectomy.
    Yantong Y; Shan L; Zhijie C; Youwei Z
    Eur J Surg Oncol; 2018 Oct; 44(10):1595-1602. PubMed ID: 30041973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
    Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
    [No Abstract]   [Full Text] [Related]  

  • 9. A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort.
    Yang T; Zhang J; Lu JH; Yang LQ; Yang GS; Wu MC; Yu WF
    J Cancer Res Clin Oncol; 2011 May; 137(5):739-50. PubMed ID: 20607551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic influence of spontaneous tumor rupture on hepatocellular carcinoma after interval hepatectomy.
    Chan AC; Dai JW; Chok KS; Cheung TT; Lo CM
    Surgery; 2016 Feb; 159(2):409-17. PubMed ID: 26294087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.
    Chen TW; Chu CM; Yu JC; Chen CJ; Chan DC; Liu YC; Hsieh CB
    Eur J Surg Oncol; 2007 May; 33(4):480-7. PubMed ID: 17129701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.
    Zhang TT; Zhao XQ; Liu Z; Mao ZY; Bai L
    Clin Transl Oncol; 2016 Aug; 18(8):831-40. PubMed ID: 26577107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: Implications on the current AJCC staging system.
    Goh BK; Teo JY; Chan CY; Lee SY; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 Jan; 113(1):89-93. PubMed ID: 26611492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
    Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
    World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Serosal Invasion on Prognosis after Curative Hepatectomy for Hepatocellular Carcinoma: Invasion to Adjacent Organs and Rupture of Tumor Were Crucial Tumor-Related Prognostic Factors Needed for Survival.
    Kato Y; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Dig Surg; 2018; 35(2):155-163. PubMed ID: 28787731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging systems for predicting survival of patients with hepatocellular carcinoma after surgery.
    Xu LB; Wang J; Liu C; Pang HW; Chen YJ; Ou QJ; Chen JS
    World J Gastroenterol; 2010 Nov; 16(41):5257-62. PubMed ID: 21049561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.
    Huang J; Li BK; Chen GH; Li JQ; Zhang YQ; Li GH; Yuan YF
    J Gastrointest Surg; 2009 Sep; 13(9):1627-35. PubMed ID: 19506976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system.
    Chan AC; Fan ST; Poon RT; Cheung TT; Chok KS; Chan SC; Lo CM
    HPB (Oxford); 2013 Jun; 15(6):439-48. PubMed ID: 23659567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
    Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
    JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.